Skip to Main Content
Navigated to Duke University School of Medicine.

Duke University School of Medicine

The School of Medicine comprises eight basic departments, eighteen clinical departments, and numerous centers and institutes (several of which are highlighted below) that promote cross-institutional, multidisciplinary efforts designed to harness strengths and leverage knowledge to make significant contributions to science, medicine, and human health.

Duke-NUS Graduate Medical School Singapore

Duke-NUS is Singapore’s first and only medical school, combining the unique medical education curriculum at Duke with the academic rigor and rich resources offered by the National University of Singapore (NUS). It offers students an enriching and innovative educational experience. Graduates of the Doctor of Medicine (MD) program are awarded a joint MD degree by Duke and NUS. The website for Duke-NUS Graduate Medical School Singapore is

Duke Human Vaccine Institute

The Duke Human Vaccine Institute (DHVI) has established a place of national and international leadership in the fight against major infectious diseases including HIV, Influenza, and COVID-19. DHVI is a pioneer in emerging infections and biodefense research. DHVI investigators continue to make significant contributions to overcome global health challenges on behalf of society.

Duke Cancer Institute

The Duke Cancer Institute (DCI) unites hundreds of cancer physicians, researchers, educators, and staff under a shared administrative structure to accelerate research advances related to cancer and improve Duke’s ability to translate these discoveries into the most advanced cancer care for patients. In 2022, the DCI celebrated its fiftieth Anniversary as a National Cancer Institute (NCI)-designated “comprehensive cancer center.” NCI-Designated Cancer Centers are recognized for their scientific leadership, resources, and the depth and breadth of their research in basic, clinical, and/or population science.

Duke Clinical and Translational Science Institute (CTSI)

The Duke Clinical and Translational Science Institute (CTSI) is the administrative home for the Duke Clinical and Translational Science Award (CTSA), overseeing and integrating sixteen CTSA core services in the fabric of translational science at Duke University. In 2018, the CTSI was awarded a five-year grant of more than $60 million from the National Institutes of Health (NIH) to advance innovative ideas from the point of discovery to implementation in clinical practice and population health. Duke received one of the original twelve CTSA grants in 2006, with a previous renewal in 2013.

Global Health Institute

Duke’s Global Health Institute (DGHI) is a university-wide effort to address health disparities worldwide through multidisciplinary research, education, policy engagement, and service. DGHI’s education, research, and capacity building initiatives are built on a strong network of partnerships with institutions around the world.

Duke Clinical Research Institute

Known for conducting groundbreaking multi-national clinical trials, managing major national patient registries, and performing landmark outcomes research, the Duke Clinical Research Institute (DCRI) conducts research that spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics.